VIVIMEDLAB.NSVIVIMEDLAB.NSNSE
Loading
Year-over-year operating income growth rate
Latest
-10.65%
↑ 97% vs avg
Percentile
P44
Within normal range
Streak
1 qtr
Consecutive declineDecelerating
Average
-399.68%
Historical baseline
| Period | Value |
|---|---|
| Q3 2025 | -10.65% |
| Q2 2025 | 33.51% |
| Q1 2025 | -43.26% |
| Q4 2024 | -17.25% |
| Q3 2024 | 68.41% |
| Q2 2024 | -453.38% |
| Q1 2024 | 223.78% |
| Q4 2023 | 59.18% |
| Q3 2023 | -71.04% |
| Q2 2023 | 98.11% |
| Q1 2023 | -2753.88% |
| Q4 2022 | 31.00% |
| Q3 2022 | -1.20% |
| Q2 2022 | -173.49% |
| Q1 2022 | 59.44% |
| Q4 2021 | 20.79% |
| Q3 2021 | -337.00% |
| Q2 2021 | 133.45% |
| Q1 2021 | 45.06% |
| Q4 2020 | -13096.04% |
| Q3 2020 | -100.88% |
| Q2 2020 | 239.40% |
| Q1 2020 | 6.15% |
| Q4 2019 | -25.21% |
| Q3 2019 | -174.06% |
| Q2 2019 | 9.05% |
| Q1 2019 | 3.21% |
| Q4 2018 | -29.95% |
| Q3 2018 | -42.15% |
| Q2 2018 | 165.95% |
| Q1 2018 | -4.72% |
| Q4 2017 | -18.96% |
| Q3 2017 | -52.86% |
| Q2 2017 | -68.53% |
| Q1 2017 | 105.50% |
| Q4 2016 | 169.72% |
| Q3 2016 | -12.44% |
| Q2 2016 | 6.60% |
| Q1 2016 | 26.27% |
| Q4 2015 | -5.00% |